REED - Revista Española de Enfermedades Digestivas

New issue alert	Contact
Submit a manuscript	Follow REEDigestivas_
Versión en español

Year 2024 / Volume 116 / Number 3
Review

Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis

148-156

DOI: 10.17235/reed.2022.8472/2021

Hui Zhang, Mengqi Yin, Yu Hu, Mingming Jiang, Mingliang Lu, Yajuan Wu,

Abstract

Background: colorectal cancer (CRC) is the most common carcinoma worldwide, but a lack of effective prognostic markers limits clinical diagnosis and treatment. Yes-associated protein 1 (YAP1) is an effector of the HIPPO-pathway, which plays a critical role in cancer development and prognosis, including CRC. However, previous reports have suggested that it plays a dual role in CRC. Methods: a meta-analysis using RevMan 5.4 and Stata 14.0 was performed to evaluate the relationship between YAP1 and clinical outcomes of CRC, after searching for eligible studies in the PubMed, Web of Science and Embase databases. Online datasets GEPIA and LOGpc were also used to calculate survival results and for comparison with the meta-analysis results. Besides, “DESeq” packages were used for the expression analysis of YAP1 from the TCGA dataset. Results: YAP1 was overexpressed in the cancer tissues when compared to normal tissues in patients with CRC from the TCGA database (p = 0.000164) and GEPIA database. A total of 10 studies involving 2305 patients from the literature were selected. Pooled HR indicated that overexpression of YAP1 was associated with poor clinical outcomes (HR = 1.70, 95 % CI: 1.28-2.26, p = 0.0003). Subgroup analysis showed a clear correlation between overexpression of YAP1 and worse survival rate in Chinese patients (HR = 1.94, 95 % CI: 1.40-2.69, p = 0.0001), nuclear YAP1 overexpression (HR = 2.07, 95 % CI: 1.29-3.31, p = 0.003), 60 months of follow-up (HR = 1.89, 95 % CI: 1.30-2.73, p = 0.0008), IHC test (HR = 1.65, 95 % CI: 1.17-2.33, p = 0.005), IHC combined with other tests (HR = 1.77, 95 % CI: 1.13-2.77, p = 0.01) and multivariate analysis (HR = 1.70, 95 % CI: 1.24-2.31, p = 0.0009). Nevertheless, disease-free survival (DFS) showed no significant results in the patients with CRC in our meta-analysis (HR = 1.38, 95 % CI: 0.51-3.75, p = 0.52) as well as in the GEPIA and LOGpc databases. Meanwhile, YAP1 overexpression was also significantly associated with worse overall survival (OS) in GSE17536, GSE40967, GSE29623 and GSE71187. Conclusion: YAP1 overexpression is common in CRC tissues. Overexpression of YAP1 in CRC patients, particularly in the nucleus, might be related to shorter OS, maybe in the early stages. YAP1 could serve as a potential predictor of poor prognosis in CRC.

New comment

Comments

No comments for this article

References

1. Read, B. and P. Sylla, Aggressive Colorectal Cancer in the Young. Clin Colon Rectal Surg, 2020. 33(5): p. 298-304.

DOI: 10.1055/s-0040-1713747

2. Recio-Boiles, A. and B. Cagir, Colon Cancer, in StatPearls. 2021: Treasure Island (FL).

3. Dekker, E., et al., Colorectal cancer. Lancet, 2019. 394(10207): p. 1467-1480.

DOI: 10.1016/S0140-6736(19)32319-0

4. Gu, M. and S. Thapa, Colorectal cancer in the United States and a review of its heterogeneity among Asian American subgroups. Asia Pac J Clin Oncol, 2020. 16(4): p. 193-200.

DOI: 10.1111/ajco.13324

5. Fisher, K.W., et al., Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus. Future Oncol, 2015. 11(19): p. 2711-2719.

DOI: 10.2217/fon.15.219

6. Hardingham, J.E., et al., Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress. Mol Med, 2015. 21 Suppl 1: p. S25-31.

DOI: 10.2119/molmed.2015.00149

7. Edgar, B.A., From cell structure to transcription: Hippo forges a new path. Cell, 2006. 124(2): p. 267-73.

DOI: 10.1016/j.cell.2006.01.005

8. Hong, A.W., Z. Meng, and K.L. Guan, The Hippo pathway in intestinal regeneration and disease. Nat Rev Gastroenterol Hepatol, 2016. 13(6): p. 324-37.

DOI: 10.1038/nrgastro.2016.59

9. Meng, Z., T. Moroishi, and K.L. Guan, Mechanisms of Hippo pathway regulation. Genes Dev, 2016. 30(1): p. 1-17.

DOI: 10.1101/gad.274027.115

10. Moroishi, T., C.G. Hansen, and K.L. Guan, The emerging roles of YAP and TAZ in cancer. Nat Rev Cancer, 2015. 15(2): p. 73-79.

DOI: 10.1038/nrc3876

11. Matallanas, D., et al., RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell, 2007. 27(6): p. 962-75.

DOI: 10.1016/j.molcel.2007.08.008

12. Murakami, S., et al., Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Oncogene, 2017. 36(9): p. 1232-1244.

DOI: 10.1038/onc.2016.288

13. Wu, H., et al., Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma. Tumour Biol, 2016. 37(10): p. 13499-13508.

DOI: 10.1007/s13277-016-5211-y

14. Liu, J.Y., et al., Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder. BMC Cancer, 2013. 13: p. 349.

15. Wang, Y., et al., Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer. Cancer Sci, 2010. 101(5): p. 1279-85.

DOI: 10.1111/j.1349-7006.2010.01511.x

16. Yan, H., et al., Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy. Oncol Rep, 2018. 39(4): p. 1671-1681.

DOI: 10.3892/or.2018.6252

17. Konsavage, W.M., Jr., et al., Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem, 2012. 287(15): p. 11730-9.

DOI: 10.1074/jbc.M111.327767

18. Yuan, M., et al., Yes-associated protein (YAP) functions as a tumor suppressor in breast. Cell Death Differ, 2008. 15(11): p. 1752-9.

DOI: 10.1038/cdd.2008.108

19. Barry, E.R., et al., Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature, 2013. 493(7430): p. 106-10.

DOI: 10.1038/nature11693

20. Cottini, F., et al., Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med, 2014. 20(6): p. 599-606.

DOI: 10.1038/nm.3562

21. Xu, Z., et al., YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer. Biomed Res Int, 2019. 2019: p. 2170830.

22. Li, H.L., et al., A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression. J Cancer Res Clin Oncol, 2021. 147(6): p. 1569-1585.

DOI: 10.1007/s00432-021-03604-8

23. Dong, T., et al., High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer. PeerJ, 2020. 8.

DOI: 10.7717/peerj.10397

24. Wang, Y., et al., Clinical and prognostic significance of Yes-associated protein in colorectal cancer. Tumour Biol, 2013. 34(4): p. 2169-74.

DOI: 10.1007/s13277-013-0751-x

25. Yang, R., et al., Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer. Immunology, 2018. 155(2): p. 263-272.

DOI: 10.1111/imm.12949

26. Wang, L., et al., Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells. PLoS One, 2013. 8(6): p. e65539.

DOI: 10.1371/journal.pone.0065539

27. Zhang, S., et al., Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer. J Cancer, 2019. 10(3): p. 689-696.

DOI: 10.7150/jca.28333

28. Tierney, J.F., et al., Practical methods for incorporating summary time-to-event data into meta-analysis. Trials, 2007. 8: p. 16.

29. Kim, J.Y., et al., VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer. Apmis, 2020. 128(10): p. 543-551.

DOI: 10.1111/apm.13070

30. Ou, C., et al., MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer. Cancer Letters, 2017. 399: p. 53-63.

DOI: 10.1016/j.canlet.2017.04.011

31. Sun, Z., et al., YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer. Oncogene, 2019. 38(14): p. 2627-2644.

DOI: 10.1038/s41388-018-0628-y

32. Kim, D.H., et al., Differential expression of Yes-associated protein and phosphorylated Yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma. Histol Histopathol, 2013. 28(11): p. 1483-90.

33. Weinstein, P.S., et al., Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol, 1984. 19(3): p. 193-8.

DOI: 10.1111/j.1365-3083.1984.tb00919.x

34. Duffy, M.J., et al., Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer, 2007. 43(9): p. 1348-60.

DOI: 10.1016/j.ejca.2007.03.021

35. Zhou, D., et al., Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci U S A, 2011. 108(49): p. E1312-20.

DOI: 10.1073/pnas.1110428108

36. Steinhardt, A.A., et al., Expression of Yes-associated protein in common solid tumors. Hum Pathol, 2008. 39(11): p. 1582-9.

DOI: 10.1016/j.humpath.2008.04.012

1. READ B, SYLLA P. Aggressive Colorectal Cancer in the Young[J]. Clin Colon Rectal Surg, 2020,33(5):298-304.

DOI: 10.1055/s-0040-1713747

2. RECIO-BOILES A, CAGIR B. Colon Cancer. StatPearls. Treasure Island (FL)2021.

3. DEKKER E, TANIS P J, VLEUGELS J L A, et al. Colorectal cancer[J]. Lancet, 2019,394(10207):1467-1480.

DOI: 10.1016/S0140-6736(19)32319-0

4. GU M, THAPA S. Colorectal cancer in the United States and a review of its heterogeneity among Asian American subgroups[J]. Asia Pac J Clin Oncol, 2020,16(4):193-200.

DOI: 10.1111/ajco.13324

5. FISHER K W, LOPEZ-BELTRAN A, MONTIRONI R, et al. Precision medicine in colorectal cancer: evolving genomic landscape and emerging consensus[J]. Future Oncol, 2015,11(19):2711-2719.

DOI: 10.2217/fon.15.219

6. HARDINGHAM J E, GROVER P, WINTER M, et al. Detection and Clinical Significance of Circulating Tumor Cells in Colorectal Cancer--20 Years of Progress[J]. Mol Med, 2015,21 Suppl 1:S25-31.

DOI: 10.2119/molmed.2015.00149

7. EDGAR B A. From cell structure to transcription: Hippo forges a new path[J]. Cell, 2006,124(2):267-273.

DOI: 10.1016/j.cell.2006.01.005

8. HONG A W, MENG Z, GUAN K L. The Hippo pathway in intestinal regeneration and disease[J]. Nat Rev Gastroenterol Hepatol, 2016,13(6):324-337.

DOI: 10.1038/nrgastro.2016.59

9. MENG Z, MOROISHI T, GUAN K L. Mechanisms of Hippo pathway regulation[J]. Genes Dev, 2016,30(1):1-17.

DOI: 10.1101/gad.274027.115

10. MOROISHI T, HANSEN C G, GUAN K L. The emerging roles of YAP and TAZ in cancer[J]. Nat Rev Cancer, 2015,15(2):73-79.

DOI: 10.1038/nrc3876

11. MATALLANAS D, ROMANO D, YEE K, et al. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein[J]. Mol Cell, 2007,27(6):962-975.

DOI: 10.1016/j.molcel.2007.08.008

12. MURAKAMI S, SHAHBAZIAN D, SURANA R, et al. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma[J]. Oncogene, 2017,36(9):1232-1244.

DOI: 10.1038/onc.2016.288

13. WU H, LIU Y, JIANG X W, et al. Clinicopathological and prognostic significance of Yes-associated protein expression in hepatocellular carcinoma and hepatic cholangiocarcinoma[J]. Tumour Biol, 2016,37(10):13499-13508.

DOI: 10.1007/s13277-016-5211-y

14. LIU J Y, LI Y H, LIN H X, et al. Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder[J]. BMC Cancer, 2013,13:349.

DOI: 10.1186/1471-2407-13-349

15. WANG Y, DONG Q, ZHANG Q, et al. Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer[J]. Cancer Sci, 2010,101(5):1279-1285.

DOI: 10.1111/j.1349-7006.2010.01511.x

16. YAN H, QIU C, SUN W, et al. Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy[J]. Oncol Rep, 2018,39(4):1671-1681.

DOI: 10.3892/or.2018.6252

17. KONSAVAGE W M, JR., KYLER S L, RENNOLL S A, et al. Wnt/beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells[J]. J Biol Chem, 2012,287(15):11730-11739.

DOI: 10.1074/jbc.M111.327767

18. YUAN M, TOMLINSON V, LARA R, et al. Yes-associated protein (YAP) functions as a tumor suppressor in breast[J]. Cell Death Differ, 2008,15(11):1752-1759.

DOI: 10.1038/cdd.2008.108

19. BARRY E R, MORIKAWA T, BUTLER B L, et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP[J]. Nature, 2013,493(7430):106-110.

DOI: 10.1038/nature11693

20. COTTINI F, HIDESHIMA T, XU C, et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers[J]. Nat Med, 2014,20(6):599-606.

DOI: 10.1038/nm.3562

21. XU Z, WANG H, GAO L, et al. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer[J]. Biomed Res Int, 2019,2019:2170830.

DOI: 10.1155/2019/2170830

22. LI H L, LI Q Y, JIN M J, et al. A review: hippo signaling pathway promotes tumor invasion and metastasis by regulating target gene expression[J]. J Cancer Res Clin Oncol, 2021,147(6):1569-1585.

DOI: 10.1007/s00432-021-03604-8

23. DONG T, YUAN Y, XIANG X, et al. High cytoplasmic YAP1 expression predicts a poor prognosis in patients with colorectal cancer[J]. PeerJ, 2020,8.

DOI: 10.7717/peerj.10397

24. WANG Y, XIE C, LI Q, et al. Clinical and prognostic significance of Yes-associated protein in colorectal cancer[J]. Tumour Biol, 2013,34(4):2169-2174.

DOI: 10.1007/s13277-013-0751-x

25. YANG R, CAI T-T, WU X-J, et al. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer[J]. Immunology, 2018,155(2):263-272.

DOI: 10.1111/imm.12949

26. WANG L, SHI S, GUO Z, et al. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells[J]. PLoS One, 2013,8(6):e65539.

DOI: 10.1371/journal.pone.0065539

27. ZHANG S, WEI Q, YANG Y, et al. Loss of Yes-associated Protein Represents an Aggressive Subtype of Colorectal Cancer[J]. J Cancer, 2019,10(3):689-696.

DOI: 10.7150/jca.28333

28. TIERNEY J F, STEWART L A, GHERSI D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis[J]. Trials, 2007,8:16.

DOI: 10.1186/1745-6215-8-16

29. KIM J Y, KIM E K, LEE W M, et al. VGLL4 with low YAP expression is associated with favorable prognosis in colorectal cancer[J]. Apmis, 2020,128(10):543-551.

DOI: 10.1111/apm.13070

30. OU C, SUN Z, PENG Q, et al. MiR-590-5p, a density-sensitive microRNA, inhibits tumorigenesis by targeting YAP1 in colorectal cancer[J]. Cancer Letters, 2017,399:53-63.

DOI: 10.1016/j.canlet.2017.04.011

31. SUN Z, OU C, LIU J, et al. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer[J]. Oncogene, 2019,38(14):2627-2644.

DOI: 10.1038/s41388-018-0628-y

32. KIM D H, KIM S H, LEE O J, et al. Differential expression of Yes-associated protein and phosphorylated Yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma[J]. Histol Histopathol, 2013,28(11):1483-1490.

33. WEINSTEIN P S, SKINNER M, SIPE J D, et al. Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases[J]. Scand J Immunol, 1984,19(3):193-198.

DOI: 10.1111/j.1365-3083.1984.tb00919.x

34. DUFFY M J, VAN DALEN A, HAGLUND C, et al. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use[J]. Eur J Cancer, 2007,43(9):1348-1360.

DOI: 10.1016/j.ejca.2007.03.021

35. ZHOU D, ZHANG Y, WU H, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance[J]. Proc Natl Acad Sci U S A, 2011,108(49):E1312-1320.

DOI: 10.1073/pnas.1110428108

36. STEINHARDT A A, GAYYED M F, KLEIN A P, et al. Expression of Yes-associated protein in common solid tumors[J]. Hum Pathol, 2008,39(11):1582-1589.

DOI: 10.1016/j.humpath.2008.04.012

Editorial

Population screening for colorectal cancer in Spain - A public health success with remaining challenges

DOI: 10.17235/reed.2024.10774/2024

Special Article

Strategic analysis and recommendations of the Sociedad Española de Patología Digestiva (SEPD) regarding population-based screening programs for colorectal cancer in Spain

DOI: 10.17235/reed.2024.10458/2024

Original

Prognostic value of liver stiffness in metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis

DOI: 10.17235/reed.2024.10353/2024

Original

Investigating temporal patterns of colorectal cancer incidence in Spain: a comprehensive analysis of age, period and cohort effects, 1990-2019

DOI: 10.17235/reed.2024.10317/2024

Editorial

Biostatistics for gastroenterologists. Part III - Mastering meta-analysis for beginners

DOI: 10.17235/reed.2023.10123/2023

Original

Prognostic value of neutrophil-to-lymphocyte ratio at diagnosis in colorectal cancer: propensity score analysis

DOI: 10.17235/reed.2024.10041/2023

Letter

The significance of appendectomy in the context of colorectal cancer: impacts on gut microbiota and beyond

DOI: 10.17235/reed.2023.9657/2023

Digestive Diseases Image

Spontaneous regression of a rectal cancer

DOI: 10.17235/reed.2023.9486/2023

Letter

Vaginal lesion as first manifestation of colorectal disease

DOI: 10.17235/reed.2022.9270/2022

Original

Adverse events of vonoprazan in the treatments of acid-related diseases: a systematic review and meta-analysis

DOI: 10.17235/reed.2022.9228/2022

Review

Association between platelet indices and non-alcoholic fatty liver disease: a systematic review and meta-analysis

DOI: 10.17235/reed.2022.9142/2022

Original

Underwater versus conventional endoscopic mucosal resection for sessile colorectal polyps: an updated systematic review and meta-analysis

DOI: 10.17235/reed.2022.8956/2022

Letter

Biallelic mismatch repair deficiency – A rare and troublesome genetic syndrome

DOI: 10.17235/reed.2022.8928/2022

Original

Vonoprazan vs. Lansoprazole for the treatment of endoscopic submucosal dissection induced gastric ulcer: a systematic review and meta-analysis

DOI: 10.17235/reed.2022.8863/2022

Original

Relationship between DHX15 expression and survival in colorectal cancer

DOI: 10.17235/reed.2022.8838/2022

Review

Efficacy and safety of fecal microbiota transplant for recurrent Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis

DOI: 10.17235/reed.2022.8814/2022

Letter

Altered Expression of TMEM16A in Colorectal Carcinoma and Its Clinical Significance

DOI: 10.17235/reed.2022.8756/2022

Original

Endoscopic submucosal dissection versus surgery for patients with undifferentiated early gastric cancer

DOI: 10.17235/reed.2022.8564/2021

Original

Findings in the distal and proximal colon in colonoscopy screening after positive FIT and related pre-procedure factors

DOI: 10.17235/reed.2022.8409/2021

Review

Diagnostic value of circulating microRNAs for esophageal cancer: a meta-analysis based on Asian data

DOI: 10.17235/reed.2022.8348/2021

Original

TMEM16A overexpression indicates poor prognosis in colorectal cancer patients

DOI: 10.17235/reed.2021.8292/2021

Review

Diagnostic accuracy of circulating microRNA in hepatitis B virus-related hepatocellular carcinoma: a meta-analysis based on Asian data

DOI: 10.17235/reed.2021.8139/2021

Original

Abnormal liver chemistry constitutes an independent prognostic factor of less favorable clinical course in patients with COVID-19

DOI: 10.17235/reed.2021.7842/2021

Original

High expression of NDRG3 correlates with poor prognosis in gastric cancer patients

DOI: 10.17235/reed.2021.7723/2020

Original

Low applicability of the ‘‘Six-and-twelve score” in hepatocellular carcinoma treated with Drug-Eluting Beads Transarterial Chemoembolization.

DOI: 10.17235/reed.2021.7696/2020

Original

Resumption of endoscopy in the Galician colorectal cancer screening programme after the COVID-19 lock down: patient safety results

DOI: 10.17235/reed.2020.7647/2020

Original

The impact of SARS-CoV-2 infection on the surgical management of colorectal cancer: lessons learned from a multicenter study in Spain

DOI: 10.17235/reed.2020.7460/2020

Review

Inflammatory bowel disease and solid organ transplantation

DOI: 10.17235/reed.2020.7361/2020

Original

Can we optimize CEA as a response marker in rectal cancer?

DOI: 10.17235/reed.2020.7321/2020

Review

New non-invasive biomarkers for colorectal cancer screening

DOI: 10.17235/reed.2020.7233/2020

Review

Genetic alterations in colorectal cancer: implications for the prognosis and treatment of the disease

DOI: 10.17235/reed.2020.7209/2020

Original

Regional differences in colorectal cancer mortality trends, Spain (1980-2018)

DOI: 10.17235/reed.2020.7183/2020

Review

Is endoscopic drainage better than percutaneous drainage for patients with pancreatic fluid collections? A comparative meta-analysis

DOI: 10.17235/reed.2020.7170/2020

Review

Efficacy and safety of submucosal tunneling endoscopic resection for gastric submucosal tumors: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.6989/2020

Original

Meta-analysis of protein intake on the effect of Crohn’s disease and ulcerative colitis

DOI: 10.17235/reed.2020.6851/2019

Original

Serum miR-21 and miR-210 as promising non-invasive biomarkers for the diagnosis and prognosis of colorectal cancer

DOI: 10.17235/reed.2020.6801/2019

Original

miR-101 suppresses colon cancer cell migration through the regulation of EZH2

DOI: 10.17235/reed.2020.6800/2019

Original

Sentinel lymph node mapping for metastasis detection in colorectal cancer: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.6767/2019

Letter

Prophylactic HIPEC with oxaliplatin might be of benefit in T4 and perforated colon cancer: another possible interpretation of the COLOPEC results

DOI: 10.17235/reed.2020.6755/2019

Editorial

Patient satisfaction, an indicator to consider in the colorectal cancer process

DOI: 10.17235/reed.2019.6757/2019

Letter

Medullary colorectal carcinoma. Do we really know it?

DOI: 10.17235/reed.2020.6728/2019

Original

The association of dietary β-carotene and vitamin A intake on the risk of esophageal cancer: a meta-analysis

DOI: 10.17235/reed.2020.6699/2019

Review

Comparison of the diagnostic efficacy of blue laser imaging with narrow band imaging for gastric cancer and precancerous lesions: a meta-analysis

DOI: 10.17235/reed.2020.6591/2019

Original

Impact of the implementation of a preoperative nutritional program for colorectal surgery patients

DOI: 10.17235/reed.2020.6572/2019

Original

Gastric per-oral endoscopic myotomy (G-POEM) is a promising treatment for refractory gastroparesis: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.6559/2019

Original

Elevated serum levels of interleukin-37 correlate with poor prognosis in gastric cancer

DOI: 10.17235/reed.2019.6460/2019

Original

The efficacy of glucagon-like peptide 1 receptor agonists in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials

DOI: 10.17235/reed.2020.6392/2019

Original

Elevated high mobility group A2 expression in liver cancer predicts poor patient survival

DOI: 10.17235/reed.2019.6365/2019

Original

Laparoscopic versus open pancreatoduodenectomy: a meta-analysis of randomized controlled trials

DOI: 10.17235/reed.2019.6343/2019

Original

Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer

DOI: 10.17235/reed.2019.6201/2019

Letter

Hemophagocytic syndrome, a diagnostic challenge in Gastroenterology

DOI: 10.17235/reed.2019.6200/2019

Original

The effect of marital status on the survival of patients with colorectal neuroendocrine neoplasms: an analysis of the SEER database

DOI: 10.17235/reed.2019.6183/2019

Review

Is ERCP-BD or EUS-BD the preferred decompression modality for malignant distal biliary obstruction? A meta-analysis of randomized controlled trials

DOI: 10.17235/reed.2019.6125/2018

Original

Short and long-term outcomes of underwater EMR compared to the traditional procedure in the real clinical practice

DOI: 10.17235/reed.2019.6009/2018

Letter

The rectosigmoid junction: are limits important?

DOI: 10.17235/reed.2019.5983/2018

Original

Prognostic influence of CDX2 expression in gastric carcinoma after surgery with a curative intent

DOI: 10.17235/reed.2019.5976/2018

Original

Relationship between the polyp detection rate and the post-colonoscopy colorectal cancer rate

DOI: 10.17235/reed.2019.5889/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Original

Survival and quality of life after surgery for colorectal cancer in the elderly: a comparative study

DOI: 10.17235/reed.2018.5807/2018

Review

An endoscopic or minimally invasive surgical approach for infected necrotizing pancreatitis: a systematic review and meta-analysis

DOI: 10.17235/reed.2019.5792/2018

Original

First hospital contact via the Emergency Department is an independent predictor of overall survival and disease-free survival in patients with colorectal cancer

DOI: 10.17235/reed.2019.5777/2018

Original

Analysis of rebleeding in cases of an upper gastrointestinal bleed in a single center series

DOI: 10.17235/reed.2018.5702/2018

Original

Colonic stent vs surgical resection of the primary tumor. Effect on survival from stage-IV obstructive colorectal cancer

DOI: 10.17235/reed.2020.5701/2018

Original

Satisfaction with care in colorectal cancer patients: inpatient versus outpatient study

DOI: 10.17235/reed.2019.5712/2018

Original

Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers

DOI: 10.17235/reed.2018.5509/2018

Editorial

The right colon challenge

DOI: 10.17235/reed.2018.5544/2018

Original

A meta-analysis of dietary carbohydrate intake and inflammatory bowel disease risk: evidence from 15 epidemiology studies

DOI: 10.17235/reed.2018.5490/2018

Original

Long noncoding RNAs as diagnostic biomarkers for the early detection of digestive tract cancers: a systematic review and meta-analysis

DOI: 10.17235/reed.2020.5450/2018

Original

Gastrointestinal stromal tumors: 16 years’ experience within a university hospital

DOI: 10.17235/reed.2018.5199/2017

Case Report

Serrated polyposis syndrome associated with long-standing inflammatory bowel disease

DOI: 10.17235/reed.2017.5068/2017

Editorial

Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer

DOI: 10.17235/reed.2017.5107/2017

Letter to the Editor

Neuroendocrine tumors of the pancreas: keys issues in dealing with heterogeneity

DOI: 10.17235/reed.2017.4997/2017

Letter to the Editor

Pancreatic neuroendocrine tumors. Prognostic factors

DOI: 10.17235/reed.2017.5109/2017

Letter to the Editor

Long survival in a patient with metastatic colorrectal carcinoma: reality or utopia?

DOI: 10.17235/reed.2017.4817/2016

Original

Clinical-endoscopic relevance of incidental colorectal lesions detected by PET-CT

DOI: 10.17235/reed.2018.4719/2016

Editorial

Pancreas neuroendocrine tumors - not so rare or benign

DOI: 10.17235/reed.2016.4672/2016

Original

Is it possible to predict the presence of colorectal cancer in a blood test? A probabilistic approach method

DOI: 10.17235/reed.2017.4645/2016

Letter to the Editor

Leptomeningeal carcinomatosis in a young patient with obstructive colorectal signet- ring cell adenocarcinoma

DOI: 10.17235/reed.2017.4602/2016

Original

The impact of screening on short-term outcome after surgery for colorectal cancer

DOI: 10.17235/reed.2017.4569/2016

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Original

Matrix metalloproteases expression in different histological types of colorectal polyps

DOI: 10.17235/reed.2017.4551/2016

Original

The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis

DOI: 10.17235/reed.2016.4470/2016

Original

Influence of type 2 diabetes mellitus on Khorana venous thromboembolism risk in colorectal cancer patients

DOI: 10.17235/reed.2017.4322/2016

Digestive Diseases Image

Successful balloon overtube-guided colorectal endoscopic submucosal dissection by a gastroscope

Review

Serrated lesions and serrated polyposis syndrome

DOI: 10.17235/reed.2017.4065/2015

Original

Effectiveness of three interventions to improve participation in colorectal cancer screening

DOI: 10.17235/reed.2016.4048/2015

Letter to the Editor

Endobronchial metastases of colorectal cancer

DOI: 10.17235/reed.2016.4080/2015

Original

Evaluation of large esophageal varices in cirrhotic patients by transient elastography: a meta-analysis

DOI: 10.17235/reed.2016.3980/2015

Original

Increasing incidence of colorectal cancer in the province of Salamanca. Comparison of two periods: 2004-2006 and 2010-2012

DOI: 10.17235/reed.2016.3981/2015

Original

Efficacy and safety of simeprevir in combination with peginterferon and ribavirin for patients with hepatitis C genotype 1 infection: A meta-analysis of randomized trials

DOI: 10.17235/reed.2015.3840/2015

Original

Recurrence of liver metastases from colorectal cancer and repeat liver resection

DOI: 10.17235/reed.2015.3843/2015

Original

Role of colonic microbiota in colorectal carcinogenesis: A systematic review

DOI: 10.17235/reed.2015.3830/2015

Original

Screening of enzymatic synthesis and expression of Lewis determinants in human colorectal carcinoma

DOI: 10.17235/reed.2015.3789/2015

Digestive Diseases Image

Rectosigmoid carcinoma presenting with a large small bowel fistula

Citation tools

Zhang H, Yin M, Hu Y, Jiang M, Lu M, Wu Y, et all. Prognostic analysis of Yes-associated protein 1 in patients with colorectal cancer. A systematic review and meta-analysis. 8472/2021

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics

This article has received 1082 visits.
This article has been downloaded 45 times.

Statistics from Dimensions

Statistics from Plum Analytics

Publication history

Received: 26/11/2021

Accepted: 21/09/2022

Online First: 30/09/2022

Published: 04/03/2024

Article revision time: 295 days

Article Online First time: 308 days

Article editing time: 829 days

This article hasn't been rated yet.

Reader rating:

Valora este artículo:

Submission and tracking of manuscripts

Instructions to authors

Submission and tracking

Home

Articles

Current issues

Previous issues

Cookie	Purpose	Expiration	Cookie type
ASP.NET_SessionId	Makes it possible to control traffic from the server to multiple users at the same time, identification and access as a user.	Logout / End of project	Session
cookiesDirective	Makes it possible to remember cookie settings.	Logout / End of project	Session
vercookies	Makes it possible to display the notice on the use of cookies.	Logout / End of project	Session

Download to a citation manager

Statistics from Dimensions

Statistics from Plum Analytics

Submission and tracking of manuscripts

Receive the digital monthly newsletter of the REED

In accordance with current legislation, this publication is only for health care professionals.